Press Releases

Date	News Release
05/31/2022	SteroTherapeutics Granted Orphan Drug Designation to ST-003, a Novel Drug Candidate for the Treatment of Primary Sclerosing Cholangitis
12/02/2020	SteroTherapeutics, LLC signs CRADA Agreement with NIH to Develop a Novel Treatment for Cushing Syndrome Patients
03/28/2019	SteroTherapeutics Receives New U.S. Patent for treatment of non-alcoholic Steatohepatitis (NASH)
04/04/2018	SteroTherapeutics Receives FDA Orphan-Drug Designation
02/27/2018	SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)